Relevant excerpts from article:
The Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) today welcomed NIH Director Jay Bhattacharya, MD, PhD, for a visit highlighting collaborative research, innovation and academic programs advancing public health and biomedical discovery.
The visit included a roundtable discussion on research priorities, infrastructure needs and strategies to strengthen support for biomedical research and commercialization. Three company CEOs and two of the Blumberg Institute’s most entrepreneurial scientists participated. They are:
Lillian W. Chiang, PhD, MBA, CEO of Evrys Bio,
Oren Gilad, PhD, president and CEO of Aprea Therapeutics Inc.,
Allen B. Reitz, PhD, founder and CEO of Fox Chase Therapeutics Discovery Inc.,
Jinhong Chang, MD, PhD, the Blumberg Institute’s Harvey J. Alter Professor and vice president for drug development, and
Richard G. Pestell, MD, PhD, FACP, FRACP, MBA, distinguished professor at the Blumberg Institute, cancer researcher and serial entrepreneur.
Full article here:
https://blumberginstitute.org/nih-director-vi...gy-center/
Details on Dr. Pestell's CYDY role can be found here:
https://www.cytodyn.com/our-team/leadership-team
_______________
I remain... #BULLISH!
https://www.youtube.com/watch?v=CsrWzRiRitg